Alpha 2.0
Login Register
» Articles » PMID: 8491062

Crossover Studies: a Modified Analysis with More Power

Overview
Journal Clin Pharmacol Ther
Publisher Wiley
Specialty Pharmacology
Date 1993 May 1
PMID 8491062
Citations 9
Authors
T J Cleophas
Affiliations
Soon will be listed here.
Citing Articles

The 2022 Ferno Award Address: CrEATE, an Efficient Crossover Evaluation of Addiction Treatment Efficacy.

Perkins K Nicotine Tob Res. 2022; 25(1):77-85.

PMID: 35671343 PMC: 9717395. DOI: 10.1093/ntr/ntac139.

Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Perkins K, Chengappa K, Karelitz J, Boldry M, Michael V, Herb T Neuropsychopharmacology. 2017; 43(6):1334-1342.

PMID: 29185480 PMC: 5916362. DOI: 10.1038/npp.2017.292.

Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence.

Perkins K, Karelitz J, Michael V Exp Clin Psychopharmacol. 2017; 25(4):249-254.

PMID: 28650184 PMC: 5546939. DOI: 10.1037/pha0000134.

Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.

Perkins K, Karelitz J, Michael V, Fromuth M, Conklin C, Chengappa K Nicotine Tob Res. 2015; 18(1):74-8.

PMID: 25895948 PMC: 4881827. DOI: 10.1093/ntr/ntv085.

An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.

Perkins K, Lerman C Psychopharmacology (Berl). 2013; 231(1):1-11.

PMID: 24297304 PMC: 3910509. DOI: 10.1007/s00213-013-3364-6.